NCT06841367

Brief Summary

Preeclampsia is a multisystem disease that occurs during pregnancy and carries risks into the postpartum period. This condition, which threatens maternal and fetal health, requires close monitoring and good care. Pregnant women need to rely on both their previously used coping mechanisms and learn new coping methods to manage the stress associated with high-risk pregnancies. Complementary and integrative therapies are utilized in managing hypertensive disorders and anxiety during pregnancy. Literature reviews show that complementary medicine practices included in current care may be effective in alleviating the symptoms of preeclampsia and reducing anxiety levels. However, the existing scientific studies are not at a sufficient level of evidence, and more advanced studies are needed in this area. The aim of our thesis study is to examine the effect of mindfulness-based stress reduction training on anxiety levels and physiological parameters in pregnant women diagnosed with preeclampsia.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2025

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 18, 2025

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 24, 2025

Completed
5 days until next milestone

Study Start

First participant enrolled

March 1, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 5, 2025

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 15, 2025

Completed
Last Updated

February 24, 2025

Status Verified

February 1, 2025

Enrollment Period

2 months

First QC Date

February 18, 2025

Last Update Submit

February 21, 2025

Conditions

Keywords

preeclampsiaanxiety levelphysiological parameters

Outcome Measures

Primary Outcomes (1)

  • State-Trait Anxiety Inventory

    The State-Trait Anxiety Inventory was developed by Spielberger and colleagues to measure state anxiety and trait anxiety. The final value obtained represents the individual's anxiety score. The scores obtained from both scales theoretically range between 20 and 80. A higher score indicates a higher level of anxiety. A lower score indicates a lower level of anxiety.

    two months

Secondary Outcomes (3)

  • measurement of physiological parameters / arterial blood

    two months

  • measurement of physiological parameters / heart rate

    two months

  • measurement of physiological parameters / fever

    two months

Study Arms (2)

mindfulness-based stress reduction training

EXPERIMENTAL

The participants' anxiety levels and physiological parameters will be measured at the initial stage. For 8 weeks in the intervention group, conscious awareness-based stress reduction training will be given online for 1 hour a week. Control at week 4 and Interim evaluations will be provided for intervention groups. At the end of the 8th week, anxiety level and physiological parameters were again will be evaluated.

Other: Mindfulness-based stress reduction training

Control group

NO INTERVENTION

The participants' anxiety levels and physiological parameters will be measured at the initial stage. No intervention will be made to the control group. Physiological parameters and anxiety levels will be measured at the 4th and 8th weeks.

Interventions

It is expected that improvements in physiological parameters and anxiety levels will be observed in the preeclampsia group with awareness-based stress reduction training.

mindfulness-based stress reduction training

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsIt is aimed to ensure that pregnant women are minimally affected by the preeclampsia diagnosis they receive.
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Knowing Turkish
  • Being literate
  • Being over 18
  • Being primiparous
  • Having a singleton fetus and cephalic presentation
  • Being diagnosed with preeclampsia
  • Agreeing to participate in the study

You may not qualify if:

  • Having any additional disease other than preeclampsia
  • Participant's voluntary withdrawal from the study
  • Having a cesarean section for any reason

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pre-Eclampsia

Condition Hierarchy (Ancestors)

Hypertension, Pregnancy-InducedPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Istanbul University-Cerrahpaşa Faculty of Health Sciences Postgraduate Education Institute, ASSOCIATE PROFESSOR

    husniye.dinckaya@iuc.edu.tr

    PRINCIPAL INVESTIGATOR
  • SERTAP MANTARCI, MIDWIFERY GRADUATE STUDENT

    sertap.mantarci@gmail.com

    PRINCIPAL INVESTIGATOR

Central Study Contacts

SERTAP MANTARCI, MIDWIFERY GRADUATE STUDENT

CONTACT

HÜSNİYE DİNÇ KAYA, ASSOCIATE PROFESSOR

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
The control group will not receive mindfulness-based stress reduction training, and outcome assessments will be conducted by a researcher dependent on group allocation.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: It is a study with a randomized controlled experimental design. Two groups with preeclampsia will be included in the study. Experimental group (group receiving mindfulness training), Control group (group without intervention)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 18, 2025

First Posted

February 24, 2025

Study Start

March 1, 2025

Primary Completion

May 5, 2025

Study Completion

July 15, 2025

Last Updated

February 24, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share